|
RYK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.138000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.042400E-01 |
| Normal-vs-Stage2 |
1.088040E-01 |
| Normal-vs-Stage3 |
1.968120E-02 |
| Normal-vs-Stage4 |
5.264600E-03 |
| Stage1-vs-Stage2 |
2.725400E-01 |
| Stage1-vs-Stage3 |
6.161800E-02 |
| Stage1-vs-Stage4 |
1.623870E-02 |
| Stage2-vs-Stage3 |
8.226000E-01 |
| Stage2-vs-Stage4 |
5.458600E-01 |
| Stage3-vs-Stage4 |
6.092400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.212820E-01 |
| Normal-vs-AfricanAmerican |
9.901000E-01 |
| Normal-vs-Asian |
7.104400E-01 |
| Caucasian-vs-AfricanAmerican |
2.752800E-01 |
| Caucasian-vs-Asian |
3.045800E-01 |
| AfricanAmerican-vs-Asian |
7.726800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.159700E-02 |
| Normal-vs-Female |
1.329430E-01 |
| Male-vs-Female |
1.668020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.265200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.754300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.880500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.660370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.463600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.821530E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.978600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.593790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.508400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.782600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.942800E-03 |
| Classical-VS-Follicular |
2.244000E-02 |
| Classical-VS-Other |
8.590400E-01 |
| Classical-VS-Normal |
5.212000E-01 |
| Tall-VS-Follicular |
5.300800E-01 |
| Tall-VS-Other |
2.414200E-01 |
| Tall-VS-Normal |
5.237000E-03 |
| Follicular-VS-Other |
5.621200E-01 |
| Follicular-VS-Normal |
1.988130E-02 |
| Other-VS-Normal |
6.489000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.133900E-02 |
| Normal-vs-N1 |
2.283800E-02 |
| N0-vs-N1 |
4.921600E-01 |
|
|
